Clinical trials
Observational Eczema trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
33 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 2 |
| 2005 | 2 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 2 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 2 |
| 2018 | 4 |
| 2019 | 1 |
| 2020 | 4 |
| 2021 | 1 |
| 2022 | 3 |
| 2023 | 2 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 16 |
| Recruiting | 7 |
| Active, not recruiting | 3 |
| Enrolling by invitation | 2 |
| Unknown status | 2 |
| Withdrawn | 2 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Incyte Corporation | 2 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 2 |
| ProgenaBiome | 2 |
| University of California, San Francisco | 2 |
| Boston Children's Hospital | 1 |
| Castle Biosciences Incorporated | 1 |
| Global Healthy Living Foundation | 1 |
| Indiana University | 1 |
| Johns Hopkins University | 1 |
| Mayo Clinic | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eczema | 33 |
| Dermatitis, Atopic | 25 |
| Psoriasis | 5 |
| Acne Vulgaris | 4 |
| Asthma | 4 |
| Amyotrophic Lateral Sclerosis | 3 |
| Arthritis, Rheumatoid | 3 |
| Crohn Disease | 3 |
| Diabetes Mellitus | 3 |
| Hypersensitivity | 3 |
Trials
Showing 1 to 25 of 33. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.